{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:40:47Z","timestamp":1759898447082,"version":"build-2065373602"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune disorder associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD) that is not fully explained by traditional risk factors. This study investigated whether a novel microRNA (hsa-miR) panel could improve cardiovascular risk prediction and stratification in RA patients. In this 8-year prospective cohort study, 235 RA patients were enrolled, of whom 148 completed follow-up. We quantified six hsa-miRs (hsa-miR-24, -146, -Let7a, -425, -451, and -155-5p) using qPCR and evaluated their predictive value for two primary endpoints: ASCVD progression (new atherosclerotic plaques and\/or non-fatal cardiovascular events) and all-cause mortality using partial least squares discriminant analysis (PLS-DA), linear mixed models, and multivariate regression. During follow-up, 58 patients (39%) experienced ASCVD progression, and 35 died (ASCVD accounting for 31% of deaths). PLS-DA models indicated that baseline hsa-miR levels predicted both ASCVD progression and mortality, explaining 43% and 42% of outcome variability, respectively. Longitudinal changes in five hsa-miRs (-24, -146, -let-7a, -425, and -155-5p) also predicted ASCVD progression. Age, hypertension, and disease duration modulated hsa-miR expression levels over time. This hsa-miR panel represents a promising tool for improving cardiovascular risk prediction in RA, potentially addressing critical gaps in current stratification approaches. Following validation, it could support implementation of personalized cardiovascular risk assessment in RA clinical practice.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1667553","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:18:05Z","timestamp":1759897085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Atherosclerotic cardiovascular disease and mortality in a cohort of patients with rheumatoid arthritis: a prospective study investigating microRNAs as predictors of atherosclerosis and mortality"],"prefix":"10.3389","volume":"16","author":[{"given":"D\u00eddac","family":"Llop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiana","family":"Ibarretxe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roser","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Masana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Ribalta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Carles","family":"Vallv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume-title":"The Lancet","author":"Smolen","year":"2016"},{"key":"B2","doi-asserted-by":"publisher","first-page":"417-28","DOI":"10.1038\/s41584-023-00969-7","article-title":"Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease","volume":"19","author":"Weber","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.143396","article-title":"The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study","volume":"70","author":"Lindhardsen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.03.011","article-title":"Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study","volume":"50","author":"Corrales","year":"2020","journal-title":"Semin Arthritis Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01001-5","article-title":"Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease","volume":"21","author":"Caporali","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/cells12121629","article-title":"Clinical significance of microRNAs, long non-coding RNAs, and CircRNAs in cardiovascular diseases","volume":"12","author":"Singh","year":"2023","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2898-x","article-title":"MicroRNAs in rheumatoid arthritis","volume":"34","author":"Salehi","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.3390\/ijms23073996","article-title":"Circulating microRNAs in Medicine","volume":"23","author":"Pozniak","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2018.30","article-title":"miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-305402","article-title":"MicroRNAs in cardiovascular disease: an introduction for clinicians","volume":"101","author":"Romaine","year":"2015","journal-title":"Heart"},{"key":"B11","article-title":"Plasma circulating microRNAs in patients with stable coronary artery disease \u2013 Impact of different cardiovascular risk profiles and glomerular filtration rates","volume":"7","author":"Trusinskis","year":"2021","journal-title":"J Clin Transl Res"},{"key":"B12","article-title":"MicroRNA differential expression shared between rheumatoid arthritis and acute myocardial infarction: an exploratory study","volume":"37","author":"Paredes","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15670","DOI":"10.1038\/s41598-021-95234-w","article-title":"Plasma expression of microRNA-425-5p and microRNA-451a as biomarkers of cardiovascular disease in rheumatoid arthritis patients","volume":"11","author":"Taverner","year":"2021","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac483","article-title":"A panel of plasma microRNAs improves the assessment of surrogate markers of cardiovascular disease in rheumatoid arthritis patients","volume":"62","author":"Llop","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015347","article-title":"Plasma expression of carotid plaque presence-related microRNAs is associated with inflammation in patients with rheumatoid arthritis","volume":"24","author":"Llop","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7437281","article-title":"miR-155: an important role in inflammation response","volume":"2022","author":"Hu","year":"2022","journal-title":"J Immunol Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2018.0155","article-title":"MicroRNA-155: A master regulator of inflammation","volume":"39","author":"Mahesh","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01932","article-title":"MicroRNA-155-at the critical interface of innate and adaptive immunity in arthritis","volume":"8","author":"Alivernini","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"200355","DOI":"10.1016\/j.ijcrp.2024.200355","article-title":"The role of miR-155 in cardiovascular diseases: Potential diagnostic and therapeutic targets","volume":"24","author":"Zhang","year":"2025","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.32.4.324","article-title":"Plasma MicroRNAs (miR-146a, miR-103a, and miR-155) as Potential Biomarkers for Rheumatoid Arthritis (RA) and Disease Activity in Iranian Patients","volume":"32","author":"Bagheri-Hosseinabadi","year":"2021","journal-title":"Mediterr J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/ncrna7030039","article-title":"Functional role of miR-155 in the pathogenesis of diabetes mellitus and its complications","volume":"7","author":"Jankauskas","year":"2021","journal-title":"Noncoding RNA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1038\/s41598-019-41069-5","article-title":"Assessment of arterial stiffness variables in patients with rheumatoid arthritis: A mediation analysis","volume":"9","author":"Taverner","year":"2019","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193690","article-title":"Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age","volume":"13","author":"Taverner","year":"2018","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bj\u00f6rkegren","year":"2022","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000343145","article-title":"Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011)","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11103-012-9885-2","article-title":"miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs","volume":"80","author":"Xie","year":"2012","journal-title":"Plant Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.124.23418","article-title":"Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism","volume":"81","author":"V\u00e9kony","year":"2024","journal-title":"Hypertension"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1261\/rna.939908","article-title":"Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues","volume":"14","author":"Peltier","year":"2008","journal-title":"RNA"},{"key":"B29","doi-asserted-by":"crossref","unstructured":"Diggle\n              P\n            \n            \n              Heagerty\n              P\n            \n            \n              Liang\n              K\n            \n            \n              Zeger\n              SL\n            \n          \n          Analysis of longitudinal data\n          \n          2002","DOI":"10.1093\/oso\/9780198524847.001.0001"},{"key":"B30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.7861\/clinmed.2020-0727","article-title":"Update on the diagnosis and management of early rheumatoid arthritis","volume":"20","author":"Taylor","year":"2020","journal-title":"Clin Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.3390\/cells10123291","article-title":"COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges","volume":"10","author":"Dewanjee","year":"2021","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Kaptoge","year":"2012","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3324\/haematol.2016.144055","article-title":"A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study","volume":"101","author":"Bonaccio","year":"2016","journal-title":"Haematologica"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2211-9","DOI":"10.1007\/s10067-020-05573-8","article-title":"Plasma miRNAs improve prediction of coronary atherosclerosis in patients with rheumatoid arthritis","volume":"40","author":"Ormseth","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181029","article-title":"Development and validation of a microRNA panel to differentiate between patients with rheumatoid arthritis or systemic lupus erythematosus and controls","volume":"47","author":"Ormseth","year":"2020","journal-title":"J Rheumatol"},{"key":"B37","article-title":"MiR-451 inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion in rheumatoid arthritis through mediating p38MAPK signaling pathway","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7767598","article-title":"MicroRNA-146: biomarker and mediator of cardiovascular disease","volume":"2022","author":"Mahdavi","year":"2022","journal-title":"Dis Markers"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13338","article-title":"MiR-146a levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis","volume":"21","author":"Bae","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4162\/nrp.2016.10.4.377","article-title":"Involvement of miR-let7A in inflammatory response and cell survival\/apoptosis regulated by resveratrol in THP-1 macrophage","volume":"10","author":"Song","year":"2016","journal-title":"Nutr Res Pract"},{"key":"B41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.55563\/clinexprheumatol\/4me6tg","article-title":"Identification of circulating miR-22-3p and let-7a-5p as novel diagnostic biomarkers for rheumatoid arthritis","volume":"40","author":"Tang","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13202","article-title":"Role of microRNA-155 in rheumatoid arthritis","volume":"20","author":"Su","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201202318","article-title":"MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways","volume":"5","author":"Cheng","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/genes12081184","article-title":"MiRNA Let-7a and Let-7d are induced by globotriaosylceramide via NF-kB activation in fabry disease","volume":"12","author":"Maier","year":"2021","journal-title":"Genes (Basel)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"198:111547","DOI":"10.1016\/j.mad.2021.111547","article-title":"MicroRNA profiles of human peripheral arteries and abdominal aorta in normal conditions: MicroRNAs-27a-5p, -139-5p and -155-5p emerge and in atheroma too","author":"Collura","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.kjms.2018.05.008","article-title":"Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure","volume":"34","author":"Wang","year":"2018","journal-title":"Kaohsiung J Med Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000603","article-title":"Integrative roles of microRNAs in lipid metabolism and dyslipidemia","volume":"30","author":"Sedgeman","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11906-016-0696-8","article-title":"Role of microRNA in endothelial dysfunction and hypertension","volume":"18","author":"Nemecz","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mehy.2020.110448","article-title":"Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19","author":"Roganovi\u0107","year":"2021","journal-title":"Med Hypotheses"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1667553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:18:08Z","timestamp":1759897088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1667553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2025.1667553"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667553","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"article-number":"1667553"}}